Impaired neutrophil-mediated cell death drives Ewing's Sarcoma in the background of Down syndrome

Front Oncol. 2024 Oct 3:14:1429833. doi: 10.3389/fonc.2024.1429833. eCollection 2024.

Abstract

Introduction: Ewing Sarcoma (EWS) has been reported in seven children with Down syndrome (DS). To date, a detailed assessment of this solid tumour in DS patients is yet to be made.

Methods: Here, we characterise a chemo-resistant mediastinal EWS in a 2-year-old DS child, the youngest ever reported case, by exploiting sequencing approaches.

Results: The tumour showed a neuroectodermal development driven by the EWSR1-FLI1 fusion. The inherited myeloperoxidase deficiency of the patient caused failure of neutrophil-mediated cell death and promoted genomic instability.

Discussion: In this context, the tumour underwent genome-wide near haploidisation resulting in a massive overexpression of pro-inflammatory cytokines. Recruitment of defective neutrophils fostered rapid evolution of this EWS.

Keywords: Down syndrome; Ewing Sarcoma; genomics; inflammation; neutrophils; paediatric bone sarcoma; transcriptomics.

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The research leading to these results has received funding from AIRC under MFAG 2017 ID 20566 and BRIDGE 2023 ID 28739 (to MC), Ricerca Finalizzata 2019 ID GR-2019-12368827 (to MC), FPRC 5xmille 2018 Ministero Salute, project “ADVANCE/A-Bi-C”: Italian Ministry of Health, Ricerca Corrente 2021 (to MC), Compagnia di San Paolo (to MC and FF), and Fondazione Umberto Veronesi (to FF).